메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
ERCC1 is a DNA repair gene and has been associated with resistance to DNA damaging agents. In this study we hypothesized that a polymorphism of ERCC1 Asn118Asn (C→T) might afect the platinum-re-sistance of epithelial ovarian cancer patients to platinum-taxane chemotherapy administered post-operatively. Using the SNapShot assay, we assessed this polymorphism in ERCC1 in 60 ovarian cancer patients. Platinum-resistance was defined as pro-gression on platinum-based chemotherapy or re-currence within 6 months of completing therapy. Although not significant, platinum-resistance was less frequently observed in patients with the C/T + T/T genotype (P= 0.064). Multivariate analysis showed that the C/T + T/T genotypes constituted an inde-pendent predictive factor of reduced risk of pla-tinum-resistance in ovarian cancer (odds ratio 0.17, 95% confidence interval 0.04-0.74, P= 0.018, Fisher's exact test). No significant correlation was observed between overall survival and the ERCC1 poly-morphism. Our results suggest that genotyping of the ERCC1 polymorphism Asn118Asn may be useful for predicting the platinum-resistance of epithelial ova-rian cancer patients. However, these findings require prospective confirmation.

목차

등록된 정보가 없습니다.

참고문헌 (12)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0